Innovator drug sourcing challenges Archives

About GaBI Journal

GaBI Journal is an independent and peer reviewed academic journal. GaBI Journal encompasses all aspects of generic and biosimilar medicines development and use, from fundamental research up to clinical application and policies.

More about GaBI Journal →

Special Report – Stability Studies

The extended stability studies of anticancer therapies published in 2024 cover 21 small molecules across 10 parenteral drug groups in oncology.

More about Special Report - Stability Studies →

Current Issue

Volume 13 / Year 2024 / Issue 3

Previous Issue

Volume 13 / Year 2024 / Issue 2

Useful Links

Forthcoming Issue ▸

Recommend to a friend ▸

Request sample issue ▸

RSS feed ▸

Important Journal Links

Subscribe - Sign up

Sign up today for the weekly briefing on the latest developments in generic and biosimilar medicines!

Quick Links

Advertise ▸

Educational Workshops ▸

Glossary of Key Terms / FAQs ▸

Guidance for Guest Authors ▸

Information for Authors ▸

Library Recommendation Form ▸

Submit a Manuscript ▸

Subscribe to a print or PDF copy of GaBI Journal ▸

Support GaBI !!! ▸

Sponsor a Supplement ▸

Reprints ▸

Search results for Innovator drug sourcing challenges

Sourcing innovator products in the age of biosimilar research

About GaBI Journal

Special Report – Stability Studies

Advertisement

Current Issue

Previous Issue

Useful Links

Important Journal Links

Subscribe - Sign up

Quick Links

GaBI Journal

Explore

Framework

Outreach

Connect